Pune's Gennova Biopharmaceuticals is developing an Omicron-specific COVID-19 vaccine, a company spokesperson said on Monday. The pharmaceutical manufacturer has already filed its phase 2 data with Central Drugs Standard Control Organisation (CDSCO) on Friday, the spokesperson added.
mRNA vaccines belong to the category of nucleic acid vaccines, which use genetic material from disease-causing virus or pathogen to trigger an immune response against it within the body.
Get latest articles and stories on India at LatestLY. The testing of Gennova Biopharmaceutical s mRNA vaccine for the Omicron variant of COVID-19 is subject to regulatory approvals, the company s official spokesperson informed on Monday. India News | MRNA Vaccine Testing for Omicron Subject to Regulatory Approvals: Gennova Biopharmaceutical.
India is soon set to begin human trials on its first home-grown Covid vaccine based on Messenger RNA (mRNA) technology.Pune-based Gennova Biopharmaceuticals is making India s first mRNA vaccine known as HGC019, in collaboration with US-based .